Interprotein Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Interprotein General Information

Description

Developer of drug discovery technology intended to accelerate hit identification for protein-protein interactions. The company utilizes artificial intelligence and structure-based drug design strategies to identify hit candidates and predict compound activity, enabling pharmaceutical companies to identify new scaffolds and peptide inhibitors for challenging drug targets.

Contact Information

Formerly Known As
Inter Cyto Nano Science
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3-10-2 Toyosaki
  • Kita-ku
  • Osaka, 531-0072
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 3-10-2 Toyosaki
  • Kita-ku
  • Osaka, 531-0072
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Interprotein Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 30-Oct-2026 Completed Out of Business
1. Later Stage VC 01-May-2008 Completed Generating Revenue
To view Interprotein’s complete valuation and funding history, request access »

Interprotein Patents

Interprotein Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7896879-B2 Method for preparing dendritic cells using platelet lysates Active 04-Nov-2020
JP-2022061613-A Hsa binding protein Active 07-Oct-2020
JP-2022044216-A Prophylactic or therapeutic agents and pharmaceutical compositions for coronavirus infections (covid-19) Pending 07-Sep-2020
JP-2023075374-A Prophylactic or therapeutic agent for new coronavirus infection (covid-19) and pharmaceutical composition Pending 25-Apr-2020
JP-2023075371-A Prophylactic or therapeutic agent for new coronavirus infection (covid-19) and pharmaceutical composition Pending 03-Apr-2020
To view Interprotein’s complete patent history, request access »

Interprotein Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Interprotein FAQs

  • When was Interprotein founded?

    Interprotein was founded in 2001.

  • Where is Interprotein headquartered?

    Interprotein is headquartered in Osaka, Japan.

  • What is the size of Interprotein?

    Interprotein has 5 total employees.

  • What industry is Interprotein in?

    Interprotein’s primary industry is Drug Discovery.

  • Is Interprotein a private or public company?

    Interprotein is a Private company.

  • What is Interprotein’s current revenue?

    The current revenue for Interprotein is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process